View Cart
Microbix Logo
Request Catalogue Contact Us
Contact Us

Leading Infectious Disease Biomaterial Manufacturer

  • Copan FLOQSwab® and Liquid Control Products
    • Clinical Diagnostics,
    • Proficiency Programs,
    • Training, Verification and Development
  • Antigens for Diagnostic Test Manufacturers
  • Viral Transport Medium – DxTM™
VTM? – LEARN MORE

Microbix Reports Results for Q4 and Fiscal 2025

Full-Year Revenues of $18.6 million and Net Loss of $2.2 million   MISSISSAUGA, CANADA, December 18, 2025 - Microbix Biosystems Inc. (TSX: MBX,...
Read More

Microbix Schedules Release of Results for Q4 Fiscal 2025

Results Release and Webinar Discussion on Morning of December 18, 2025   MISSISSAUGA, CANADA, December 11, 2025 - Microbix Biosystems Inc....
Read More

Microbix Launches New Products to Support H3N2 Flu Testing

Test-Controls & Reference Materials for Labs & Test-Makers   MISSISSAUGA, CANADA, December 10, 2025 – Microbix Biosystems Inc. (TSX:...
Read More

QAPS

Why choose Microbix Quality Assessment Products (QAPs)? Find out more.

INFECTIOUS DISEASE ANTIGENS

Microbix produces one of the world’s broadest range of infectious disease antigens.

PARTNERSHIP OPPORTUNITIES

Microbix has a partnership opportunity. Check it out here.

Our Commitment to Quality

Our quality process ensures our customers receive products that meet and exceed their needs and expectations. Our quality management system takes into consideration regulatory requirements that are applicable to the type of products we manufacture and the industries we serve.